Full Recording | HCV Elimination Policy Forum - APASL 2024

The HCV Elimination Policy Forum convened on Thursday, March 28th, from 1:40 - 5:00 PM JST during the 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL) in Kyoto, Japan. This special session brought together leading clinicians, health officials, civil society members, and other influential stakeholders to discuss lessons learned, including innovative strategies, for preventing, diagnosing, and treating HCV across Asia. A call to action was presented to strengthen hepatitis elimination efforts in Asia.

The HCV Elimination Policy Forum was convened for participants attending the APASL conference. Session recording will be available here.

Agenda

Opening Remarks
Dr. John Ward, Coalition for Global Hepatitis Elimination, United States
Prof. Naoya Kato, Chiba University, Japan
Video Message | Minister Keizo Takemi, Ministry of Health, Labour and Welfare of Japan, Japan

1. Updates on Progress towards HCV Elimination | Moderator: Prof. Naoya Kato, Chiba University, Japan
Status of HCV Elimination Globally & in Asia | Dr. Philippa Easterbrook, World Health Organization
National Advances towards HCV Elimination in Asia | Dr. John Ward, Coalition for Global Hepatitis Elimination, United States

2. HCV Elimination Initiatives to Reach Marginalized Communities in Asia Pacific Countries | Moderator: Prof. Junko Tanaka, Hiroshima University, Japan
How to Reach and Treat PWUD Patients | Prof. Grace Wong, The Chinese University of Hong Kong, Hong Kong
Simplification of HCV Care in Singapore | Prof. Yew Kuo Chao, Tan Tock Seng Hospital, Singapore
Discussion

3. General Population HCV Elimination Initiatives in Asia Pacific Countries | Moderator: Prof. Ming-Lung Yu, National Sun Yat-sen University, Taiwan
Screening and Testing of Persons with Diabetes | Prof. Tsung-Hui Hu, Chang Gung Memorial Hospital, Taiwan
HCV Screening Strategies for the General Population in Japan | Prof. Tadashi Ikegami, Tokyo Medical University; Ibaraki Medical Center, Japan
HCV National Screening and Elimination Strategies in Korea | Prof. Jonggi Choi, Asan Medical Center, University of Ulsan College of Medicine, Rep. of Korea

Special Lecture | DAA-induced Paradigm Shift in HCV High Endemic Area of Japan | Prof. Masao Omata, Yamanashi Central and Kita Hospitals, Japan
Discussion

Call to Action & Closing Remarks | Dr. John Ward, Coalition for Global Hepatitis Elimination, United States